Meanwhile, Cellectis announced it now has «an umbrella patent» that its CEO, Andre Choulika, says «covers most of
the gene editing procedures done with a nuclease,» including those based on CRISPR - Cas 9, TALENs, zinc fingers, and many meganucleases.
Not exact matches
Less clear - cut are nascent techniques like
gene editing, or surgical
procedures such a head transplants.
With recent advancements in
gene editing and human cloning among scientists in China, does this mean the country now embraces these controversial
procedures?
Lastly, the
procedure involves CRISPR - Cas9 technology, which is a
gene -
editing technique that uses the immune systems of bacteria to look for genetic markers.
In addition, the
procedure also allows scientists to study
gene editing, potentially preventing genetic diseases from happening.